Skip to main content

Table 1 Demographic data for matched pairs consisting of individuals with schizophrenia and non-psychiatric controls.

From: Altered gene expression in the superior temporal gyrus in schizophrenia

Pair

Gender

Age (years) (sz/cntrl)

Medication (CPE) (mg/day)

Duration of Illness (years)

Frozen Hemisphere

Cause of Death (sz/cntrl)

PMI (hours) (sz/cntrl)

pH (sz/cntrl)

1

M

51/50

100

24

L

ischaemic heart disease/ischaemic heart disease

21/19

6.02/6.26

2

M

57/58

unknown

26

L

cardiac arrhythmia/ischaemic heart disease

33/38

6.4/6.5

3

M

52/59

450

31

R

ischaemic heart disease/coronary thrombosis

8/20

6.1/6.56

4

M

44/43

500

17

L

Suicide/thrombotic coronary artery occlusion

35/13

6.55/6.43

5

M

30/34

130–520

3.5

L

Suicide/acute exacerbation of asthma

24/20.5

6.6/6.73

6

M

32/38

780

13

L

Suicide/atherosclerotic cardiovascular disease

25/13.5

6.24/6.26

7

M

51/46

300–1300

30

R

ischaemic heart disease/cardiac arrest

18/25

6.62/6.7

8

F

67/70

150–1100

46

R

Emphema/ischaemic heart disease

27/30

6.2/6.8

9

M

75/73

200–1200

44

L

ischaemic heart disease/respiratory arrest

36/10

6.4/6.2

10

M

54/56

50–600

35

R

Coronary artery thrombosis/cardiac arrest

27/37

6.2/6.8

11

F

61/56

800–1500

42

R

ischaemic heart disease/pulmonary thromboembolus

49/23

6.7/6.7

12

M

67/69

200–2400

41

R

ischaemic heart disease/cardiovascular disease

5/16

6.4/6.6

13

M

57/56

225–975

17

R

cardiovascular disease/Cardiac atheroma

48/24

6.7/6.5

Means SZ Control

53.7 ± 13.0

54.5 ± 12.1

*637.9 ± 342.7

28.4 ± 13.2

  

27.4 ± 13.2

22.2 ± 8.7

6.4 ± 0.2

6.5 ± 0.2

  1. *calculated using the mean CPE dosage for each matched pair.